Pharma Marketing Network

JANUARY 6, 2021

Throughout the year 2020, pharma marketers were forced to explore new strategies in order to keep up with the many evolving trends. Throughout 2020, the use of telehealth and remote monitoring has also drastically increased and may continue to be popular tools used between patients and HCPs in the year 2021.

Communication 98

Communication Vaccines Pharmaceutical Companies Pharmaceutical Companies 98

pharmaphorum

DECEMBER 21, 2021

In early 2020, health officials were cautious about forecasting a COVID-19 vaccine timeline to the public, as vaccine discovery was a historically laborious process that took years (if not decades). One example of this use case is a pharmaceutical company that recently gained FDA approval for a rare cancer treatment.

Pharmaceutical Companies 113

Pharmaceutical Companies Pharmaceutical Companies Vaccines Communication 113

European Pharmaceutical Review

OCTOBER 24, 2022

In 2020-21, the loss of industry research during the pandemic is estimated to have generated an NHS deficit of up to £447 million. The report found that consistently slow and variable study setup and recruitment timelines in the NHS are forcing some pharmaceutical companies to place their trials in other countries.

Pharmaceutical Companies 75

Pharmaceutical Companies Pharmaceutical Companies Patient Care Vaccines 75

Roots Analysis

AUGUST 16, 2023

The success of COVID-19 vaccines paved the path for mRNA-based drug products. The growing interest is evident from the rise in partnership activity; in fact, the maximum number of collaborations related to mRNA-based drug manufacturing were inked in 2020 and 2021.

Vaccines 52

Vaccines Pharmaceutical Companies Pharmaceutical Companies 52

Pharmaceutical Technology

MAY 29, 2023

The global pharmaceutical industry experienced an 18% drop in company filings mentions of orphan designated drugs in Q1 2023 compared with the previous quarter, with the highest share accounted for by Horizon Therapeutics with 50% year-on-year increase, according to GlobalData’s analysis of over 182 pharmaceutical company filings.

Pharmaceutical Companies 40

Pharmaceutical Companies Pharmaceutical Companies Vaccines 40

pharmaphorum

APRIL 16, 2021

IQVIA’s Sarah Rickwood reviews the launch of innovative medicines in 2020 and outlines three key pillars of activity for companies to focus on and address in 2021. It is undeniable that 2020 was a particularly challenging year to launch non-COVID innovative prescription medicines.

Pharmaceutical Companies 81

Pharmaceutical Companies Pharmaceutical Companies Documentation Vaccines 81

pharmaphorum

NOVEMBER 24, 2020

As lockdowns started in the West during March 2020, there was, inevitably, much punditry on exit scenarios – for economies, populations, and healthcare systems. Even past the second wave, as vaccines become available, healthcare systems will not return rapidly to pre-pandemic capacities, let alone deliver more than that capacity.

Pharmaceutical Companies 73

Pharmaceutical Companies Pharmaceutical Companies Vaccines Chemotherapy 73

Pharma Marketing Network

AUGUST 26, 2020

In office/in person sales promotion, the staple of pharmaceutical company activities, is simply not possible today with interactions reduced to the sporadic video or to telephone engagement. This will result in permanent shifts in how HCPs and patients interact with pharmaceutical companies.

Pharmaceutical Companies 98

Pharmaceutical Companies Pharmaceutical Companies Vaccines Compounding 98

pharmaphorum

APRIL 27, 2022

Trust in life science companies has fluctuated since the start of the pandemic. The reputation of COVID-19 vaccine makers understandably soared early on, as clinical trials were started and completed in record time, giving hopes to millions of people in lockdown. Especially, women tend to have more distrust in pharmaceutical companies.

Vaccines 93

Vaccines Pharmaceutical Companies Pharmaceutical Companies 93

pharmaphorum

MAY 13, 2022

Its chief digital and technology officer Lidia Fonseca offered a fascinating insight into how one biggest pharmaceutical companies – and one of those most closely associated with the pandemic (alongside the likes of BioNTech, Moderna and AstraZeneca) – has been transforming itself. Digital fluency and change.

Pharmaceutical Companies 127

Pharmaceutical Companies Pharmaceutical Companies Vaccines FDA 127

pharmaphorum

JANUARY 22, 2021

Source: CRA market research (conducted June 2020). More than 100,000 MS patients were included in the data set, defined as patients with two or more MS-related medical claims or one or more MS-related medical claims plus a related pharmacy claim identified between January 2019 and June 2020. Changes in Prescribing by Specialty.

Specialty Pharmacies 98

Specialty Pharmacies Pharmaceutical Companies Pharmaceutical Companies Vaccines 98

pharmaphorum

SEPTEMBER 18, 2020

But although it was dubbed a “dangerous game”, some companies came out on top… On 6th April 1999, two companies with similar science-based cultures and a shared vision of the pharmaceutical industry came together to form what’s now considered as one of the top ten pharma companies in the world: AstraZeneca.

Vaccines 116

Vaccines Pharmaceutical Companies Pharmaceutical Companies FDA 116

pharmaphorum

FEBRUARY 26, 2021

The oceans of health data out there can be overwhelming for pharma companies to manage – but if extracted correctly, the prospect to develop drugs from scratch in as little as a year is very real, says Lifebit CEO, Maria Chatzou Dunford. The landscape for UK SMEs post-COVID.

Vaccines 59

Vaccines Pharmaceutical Companies Pharmaceutical Companies Communication 59

pharmaphorum

OCTOBER 28, 2020

A 2020 survey from DrugsDisclosed.com of 3,346 users of prescription and over the counter (OTC) medicines from the UK and the Nordics revealed that: more than three-quarters of patients do not trust advice from pharmaceutical companies about their medication; 81% feel the pharmaceutical industry influences prescription decisions; and.

Vaccines 119

Vaccines Hospitals Pharmaceutical Companies Pharmaceutical Companies 119

pharmaphorum

APRIL 11, 2022

Medicines and vaccines are among the most powerful interventions that can help improve quality of life for people across the world. The European Commission’s Pharmaceutical Strategy for Europe , adopted in November 2020, outlines a series of concrete actions to ensure accessibility, availability, and affordability of medicines.

Pharmaceutical Companies 112

Pharmaceutical Companies Pharmaceutical Companies Vaccines Packaging 112

pharmaphorum

NOVEMBER 4, 2022

While most supply chains were impacted by the Covid-19 pandemic, the demands it placed on pharmaceutical and medical supply chains were immense and underlined the importance of transparency and security. It began in January 2020 and aims to deliver an open source, blockchain-based platform for the healthcare sector.

Pharmaceutical Companies 114

Pharmaceutical Companies Pharmaceutical Companies Vaccines 114

pharmaphorum

APRIL 30, 2021

Not only has COVID forced companies, governments and healthcare systems to work towards approving drugs and vaccines in record times, the sector is also facing an influx of digital therapeutics and advanced drugs that don’t fit neatly into existing access frameworks.

Pharmaceutical Companies 91

Pharmaceutical Companies Pharmaceutical Companies Communication Vaccines 91

Pharma Marketing Network

SEPTEMBER 28, 2020

With a lack of knowledge and no known treatment, cure, or vaccine, an uncomfortable uncertainty took hold as quarantines were imposed: which people and what businesses would survive this biological blindside? The questions Pharma companies seek answers to now, and post-Covid -19, include: What will 2021 look like? What will we inspire?

Vaccines 52

Vaccines Pharmaceutical Companies Pharmaceutical Companies 52

Pharma Marketing Network

SEPTEMBER 28, 2020

With a lack of knowledge and no known treatment, cure, or vaccine, an uncomfortable uncertainty took hold as quarantines were imposed: which people and what businesses would survive this biological blindside? The questions Pharma companies seek answers to now, and post-Covid -19, include: What will 2021 look like? What will we inspire?

Vaccines 52

Vaccines Pharmaceutical Companies Pharmaceutical Companies 52

pharmaphorum

DECEMBER 14, 2021

The report, which was carried out by Vintura on behalf of the EFPIA Oncology Platform, is a follow up to 2020’s Every Day Counts – Improving Time to Patient Access to Innovative Oncology Therapies in Europe. Long and winding process.

Pharmaceutical Companies 72

Pharmaceutical Companies Pharmaceutical Companies Vaccines 72

pharmaphorum

MARCH 12, 2021

If the power of the life sciences industry to innovate and collaborate were ever in doubt, the speed at which vaccines for COVID-19 were discovered, developed, trialled, approved and manufactured have confirmed just how dynamic the industry can be. References. [1] 1] [link]. [2]

Vaccines 110

Vaccines Pharmaceutical Companies Pharmaceutical Companies Communication 110

PharmaShots

MAY 23, 2023

Was ranked the highest among the list of companies developing Cell & Gene therapy, followed by Novartis with a revenue of $50.54B and Spark Therapeutics with a revenue of $49.27B PharmaShots brings an informative report on the Top 20 Cell and Gene Therapy Companies based on the total Revenue generated in the year 2022 Total Revenue: $0.5M

FDA 58

FDA Pharmaceutical Companies Pharmaceutical Companies Immunization 58

pharmaphorum

AUGUST 13, 2020

Of these three societal pillars, it is, perhaps surprisingly, business that has stepped up to the plate most assuredly in 2020 – led by some of the world’s strongest brands. Pfizer has four different mRNA platform vaccines in play against one-another: a radical new approach for them. Government and the media didn’t fare any better.

Health and Personal Care Stores 92

Health and Personal Care Stores Vaccines Communication Pharmaceutical Companies 92

pharmaphorum

NOVEMBER 10, 2022

Horizon Europe and cancer care post-2020. With ten times more budget than before, Montserrat reminded attendees that cancer was one of the five main missions of the Horizon Europe programme, which picks up from where Horizon 2020 left off. With 90% of adolescents that should be vaccinated by 2030, Luppi deems it an opportunity.

Vaccines 89

Vaccines Pharmaceutical Companies Pharmaceutical Companies Labelling 89

Viseven

OCTOBER 26, 2022

Over the past couple of years, there have been many pharma company challenges. The global pandemic created an unprecedented demand for vaccines, shut down many clinical trials, and resulted in a worldwide PPE shortage. The pharmaceutical industry still faces significant challenges and is looking for innovative solutions.

Hospitals 52

Hospitals Vaccines Pharmaceutical Companies Pharmaceutical Companies 52

pharmaphorum

JANUARY 5, 2021

One bright spot in an otherwise dreadful year: the pharmaceutical industry has discovered it can do things it never dreamed possible. Anyone who proposed that a novel, deadly virus would spread, with a vaccine developed demonstrating 95% efficacy, and approved for patients in less than a year would have been scoffed at.

Hospitals 105

Hospitals Vaccines Pharmaceutical Companies Pharmaceutical Companies 105

pharmaphorum

SEPTEMBER 9, 2021

But when the pandemic struck in early 2020, we were found wanting. Surgical activity in England and Wales alone reduced by a third during 2020, a shortfall estimated to increase to 2.4 The aim is to work with start-up companies to generate ideas for digital therapeutics, patient support apps, and boosting research and development.

Patient Care 52

Patient Care Pharmaceutical Companies Pharmaceutical Companies Communication 52

Pharmaceutical Technology

DECEMBER 27, 2022

The Covid-19 pandemic pushed most markets into free fall, leading to increased wariness for completing large mergers and acquisitions (M&As) in the pharmaceutical sector. In 2022, Russia’s war on Ukraine struck the supply chain, eventually slowing manufacturing and causing shortages for multiple pharmaceutical companies.

FDA 52

FDA Pharmaceutical Companies Pharmaceutical Companies Vaccines 52

pharmaphorum

OCTOBER 18, 2021

The development of COVID-19 vaccines required levels of cooperation and pioneering science comparable to the Apollo space programme. Within 12 months of the outbreak, vaccines were being deployed to prevent severe infections, hospitalisation, and death. billion people have been fully vaccinated. COVID-19 vaccine tracker.

Vaccines 134

Vaccines Pharmaceutical Companies Pharmaceutical Companies Documentation 134

PharmaShots

MARCH 9, 2023

Present company and time period: Pfizer (26 yrs.) Designation: Chief Commercial Officer (CCO) and President Award & Nominations: She has her mention in Fortune’s “Top 50 Most Powerful Women” in 2020, 2021, and 2022 ranking 16th, 11th, and 13th respectively.

FDA 40

FDA Pharmaceutical Companies Pharmaceutical Companies Immunization 40

The People's Pharmacy

MAY 29, 2023

We first wrote about cimetidine for shingles in 2020. It disheartens us to discover that neither pharmaceutical companies nor public health authorities are willing to fund high-quality research to find out if cimetidine really can shorten the duration of a painful shingles attack. A Reader Wants To Know the Dose of Tagamet?

Immunization 72

Immunization Labelling Pharmaceutical Companies Pharmaceutical Companies 72

pharmaphorum

JANUARY 9, 2023

1 Kenya, for example, entered the pandemic with no human vaccines manufacturing facility and established the BioVax institute for local vaccine manufacture with a major plant investment starting in 2023. Some of the more resilient launches since 2020 have had these benefits to health systems.

Vaccines 94

Vaccines Pharmaceutical Companies Pharmaceutical Companies Documentation 94

pharmaphorum

DECEMBER 2, 2020

Similarly, in 2019 Pfizer announced a deal to merge its Upjohn generics business with Mylan, creating a combined company called Viatris. The $12 billion deal was cleared in November 2020, creating a generics behemoth with annual sales of around $19 to $20 billion and operations in 165 markets around the word.

Compounding 128

Compounding Vaccines Pharmaceutical Companies Pharmaceutical Companies 128

pharmaphorum

OCTOBER 7, 2021

Use of these platforms was however already trending up before the crisis, and there’s every sign demand will stay high from now on, according to Sjors van den Camp, commercial director at Online Seminar – a company whose heritage in this sector goes back more than a decade. The crisis that changed everything.

Communication 96

Communication Labelling Pharmaceutical Companies Pharmaceutical Companies 96

pharmaphorum

JUNE 29, 2022

COVID vaccines and treatments have created a substantial market over and above the existing Rx market- IQVIA estimates that the cumulative value of COVID vaccines could be between $185 and 295bn to 2026. On average, launches of 2020’s cohorts both underperformed. The scope of the problem. Launches, therefore, were happening.

HIV Treatment and Prevention Agents 59

HIV Treatment and Prevention Agents Vaccines Pharmaceutical Companies Pharmaceutical Companies 59

pharmaphorum

JULY 30, 2021

In a time when much of the media’s focus is on the ongoing COVID-19 pandemic and the differences in vaccination rates between various regions, countries, and socioeconomic groups, improving health literacy has never been more important. Again, vaccine hesitancy is probably the most obvious example here.

Vaccines 119

Vaccines Pharmaceutical Companies Pharmaceutical Companies Communication 119

pharmaphorum

MARCH 31, 2021

In 2020, the challenges of the COVID-19 pandemic greatly accelerated the pace of this evolution, with wide-reaching effects on many aspects of medical communications. A panel of industry experts gathered at the end of 2020 to identify some of these long-term effects, and the challenges and opportunities they pose. Conclusion.

Communication 98

Communication Pharmaceutical Companies Pharmaceutical Companies Vaccines 98